Yes. Oral weight-loss medications include prescription pills that affect appetite, fullness, or fat absorption. Oral GLP-1 research is expanding, but the right option depends on your health history, current medicines, risks, cost, and a clinician’s evaluation. Compounded tablets are not FDA-approved and should come through licensed care.9
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What are oral weight loss medications?
Oral weight-loss medications are pills used as part of weight management for some adults with obesity or overweight plus health-related complications. They work through different pathways: some reduce dietary fat absorption, while others affect brain signals involved in hunger and cravings. Obesity care is broader than a prescription alone and includes sustainable eating, movement, sleep, and follow-up support.1
Several pill types are available or under study, but they have different safety profiles. A clinician needs to look at conditions such as high blood pressure, diabetes, mental-health history, kidney or liver disease, and pregnancy plans before considering medication.2
Can you get weight loss medication as a pill?
Yes, some prescription weight-management medicines come as pills. But a pill is not automatically simpler or safer than an injection. The decision is based on the medicine’s mechanism, your other prescriptions, your medical history, and whether the expected benefit outweighs its risks.1
A medication review matters because some pills can interact with other treatments or be unsuitable with certain health conditions. If you take duloxetine and notice a change in appetite or weight, discuss it with the prescribing clinician rather than starting, stopping, or switching the medicine on your own.
Why a clinician reviews health history and current medications first
- Pregnancy and breastfeeding need special attention. WHO’s obesity guidance excludes pregnant people from GLP-1 therapy recommendations.1
- Some medicines may affect blood pressure, heart rate, mood, sleep, digestion, or blood sugar, so the full medication list matters.2
- A clinician can also help set a follow-up plan for side effects, progress, and whether the medicine still fits your goals.
Which oral weight loss medication types are available?
The main oral options use different mechanisms, so they are not interchangeable. Three common prescription categories include fat-absorption blockers and appetite-focused combination medicines. The American Gastroenterological Association guideline discusses phentermine/topiramate ER and naltrexone/bupropion ER alongside lifestyle intervention for appropriate adults with obesity.2
| Medication type | How it works | What to discuss with a clinician |
|---|---|---|
| Orlistat | Reduces absorption of some dietary fat. | Digestive effects, diet pattern, and other medicines; an orlistat-acarbose combination has also been studied in a randomized trial.4 |
| Phentermine or phentermine/topiramate | Acts on appetite-related pathways. | Blood pressure, heart history, sleep, mood, and pregnancy risk.2 |
| Naltrexone/bupropion ER | Acts on brain pathways involved in appetite and reward. | Mental-health history, seizure risk, blood pressure, and possible interactions.2 |
| Oral GLP-1 medicines | Mimic a gut hormone that helps regulate appetite and glucose-related signals. | Nausea, vomiting, diarrhea, constipation, and whether an incretin medicine fits your history.1 |
Brand names can add confusion. Wegovy and Ozempic are names associated with semaglutide, a GLP-1 receptor agonist. Zepbound and Mounjaro are names associated with tirzepatide, a dual GIP/GLP-1 receptor agonist. A diabetes indication and an obesity indication are not automatically interchangeable; the labeled product, indication, and person still matter.2
How do oral medications compare with GLP-1 injections?
There is no universal winner. Once-weekly injections may suit someone who prefers fewer dosing days, while a daily pill may better fit another person’s routine. The more important question is whether a given medicine is appropriate, tolerated, and supported by ongoing clinical follow-up.1
It is not accurate to say phentermine is simply better or worse than Ozempic. They are different medicines with different mechanisms, evidence bases, and risks. In guideline summaries, semaglutide, phentermine/topiramate ER, liraglutide, and naltrexone/bupropion ER were evaluated as medication options alongside lifestyle intervention, not as one-size-fits-all choices.2
Why there is no universal answer to whether phentermine is better than Ozempic
Semaglutide-based treatment can cause gastrointestinal adverse effects, while stimulant-containing options raise different concerns that may include sleep, mood, and cardiovascular considerations. A licensed clinician should compare these trade-offs against your conditions and current medications rather than choosing based on social media claims or a single trial result.1 2
3-min quiz
Explore clinician-guided weight-management options
At Chia, a licensed US provider reviews your health questionnaire and decides whether treatment is clinically appropriate. We offer compounded tirzepatide tablets and injections, with plans currently starting at $249 per month for tablets. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved; Chia medications are compounded in the United States by state-licensed 503A compounding pharmacies.9
What does research show about oral semaglutide and other emerging oral medicines?
Oral incretin research is moving quickly. At 64 weeks, the OASIS 4 randomized trial reported a greater mean body-weight change with 25 mg oral semaglutide than placebo among adults with overweight or obesity without diabetes, with lifestyle counseling in both groups.3 These results describe the studied active ingredient and trial regimen, not every oral product or every person’s likely outcome.
The same trial summary reported more gastrointestinal adverse events with oral semaglutide than placebo.3 Individual results vary, and people need clinician review for contraindications, current medicines, and symptoms that could make this class a poor fit.
Orforglipron is another oral medicine being studied. The ATTAIN-MAINTAIN study was a double-blind, randomized phase 3b trial of maintaining body-weight reduction.5 That is useful trial evidence, but it does not establish that every emerging oral medicine is available, appropriate, or equivalent to another medication.
What side effects and safety issues should you discuss with a clinician?
Every medication choice involves trade-offs. Gastrointestinal symptoms are common with GLP-1-based medicines, while other oral medications may have different effects on sleep, mood, blood pressure, or digestion. A medication that is effective in a trial can still be a poor match for one person.1 2
- Ask how the medicine may interact with prescriptions, over-the-counter medicines, and supplements you already use.
- Discuss pregnancy, breastfeeding, and plans to become pregnant before starting weight-management medication.1
- Seek urgent care for severe or concerning symptoms rather than trying to manage a serious reaction alone.
- Avoid sellers offering “prescription-strength” pills without a real clinical evaluation.
Why supplements marketed as weight-loss pills need extra caution
Over-the-counter supplements are not a substitute for clinician-guided prescription care. Their marketing can overstate benefits, and some supplements can have serious side effects.10 A licensed clinician and pharmacist can help review the full list of products you use.
Are compounded oral weight loss medications the same as FDA-approved medicines?
No. Compounded medications are not FDA-approved, and they should not be described as the same as, equivalent to, or interchangeable with a branded medicine. Compounded formulations do not have FDA-evaluated outcomes data for their specific formulation.9
For patients considering compounded care, the practical safety questions are about the care pathway: Is there a licensed prescriber? Is the pharmacy state-licensed? Is there clear ingredient and medication information? Will you have follow-up if questions or side effects arise? Avoid no-prescription sellers and unlicensed “research” vendors.
How does oral tirzepatide treatment work at Chia?
At Chia, 100% online care starts with a short health questionnaire. A licensed US provider reviews your history and prescribes only when clinically appropriate. If treatment is prescribed, medication is compounded by a US state-licensed 503A pharmacy and shipped to your door.
We offer tirzepatide as compounded tablets, which are not FDA-approved,9 with plans currently starting at $249 per month, and as injections, from $299 per month. Provider-guided microdosing plans are available. Our providers adjust treatment over time when appropriate, and patients can message their care team through the portal between visits.
| Chia form | Current starting price | Practical consideration |
|---|---|---|
| Compounded tirzepatide tablets | From $249/mo | A tablet option for people whose provider determines it is clinically appropriate. |
| Compounded tirzepatide injection | From $299/mo | An injection option with provider-guided dosing and follow-up. |
These compounded tirzepatide formulations are not FDA-approved, are not equivalent to branded tirzepatide products, and do not have FDA-evaluated outcomes data.9 A prescription is never guaranteed.
How can you safely get prescription weight loss pills online?
You can safely start online when the service includes a real clinical evaluation, a licensed prescriber, a legitimate pharmacy, and follow-up care. Legitimate prescription treatment includes a clinician evaluation; sellers that skip that step should be approached with caution.
Our guide to ordering weight-loss pills online explains common safety checks. You can also compare online medication models in our overview of GLP-1 medications online and read more about where to buy tirzepatide pills safely.
Frequently asked questions about oral weight loss medications
Yes. Some prescription weight-management medicines are pills, including medicines that affect fat absorption or appetite pathways. A clinician should decide whether a specific medicine fits your health history and current medicines.
Oral semaglutide has been studied for weight management, including in OASIS trials.3 Trial results do not predict every person’s result, and gastrointestinal side effects are an important part of the decision.
No. Compounded tirzepatide tablets should not be described as the same as, equivalent to, or interchangeable with branded products. Compounded medications are not FDA-approved.9
Neither is universally better. They work differently and have different risks, contraindications, and practical considerations. A clinician can help compare the options for your specific situation.
Legitimate prescription treatment includes a clinician evaluation. Avoid sellers that offer prescription medicines without reviewing your health information or providing a valid prescription process.
Weight regain can happen after medication is stopped.10 Long-term planning around nutrition, activity, follow-up, and the reason treatment is ending can help a clinician and patient prepare for that possibility.
If you notice a weight or appetite change while taking duloxetine, discuss it with the clinician who prescribed it rather than changing the medicine on your own.
3-min quiz
Start with a licensed-provider evaluation
If you are considering oral or injectable weight-management medication, Chia’s online visit starts with a clinician review of your health history and goals. Learn more about compounded tirzepatide options or compounded semaglutide injections. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved and are dispensed by state-licensed US 503A compounding pharmacies.9
References
- 1.World Health Organization. WHO issues global guideline on the use of GLP-1 medicines in treating obesity. 2025.
- 2.American Gastroenterological Association. First medical guideline recommends new prescription medications for weight loss, ranks the most effective drugs. 2022.
- 3.PCMed Project. RCT Results: Lower Dose Oral Semaglutide Weight Loss Treatment for Obesity and Overweight; summary of Wharton et al., OASIS 4 trial. 2025.
- 4.Holmbäck U, Grudén S, Litorp H, et al. Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial. Obesity. 2022.
- 5.Aronne LJ, Horn DB, le Roux CW, et al. Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial. Nature Medicine. 2026.
- 6.Garvey WT, Birkenfeld AL, Dicker D, et al. Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care. 2020.
- 7.Liu J, An Y, Yang N, et al. Longitudinal associations of dietary fiber and its source with 48-week weight loss maintenance, cardiometabolic risk factors and glycemic status under metformin or acarbose treatment: a secondary analysis of the MARCH randomized trial. Nutrition & Diabetes. 2024.
- 8.Billings LK, Winne L, Sharma P, et al. Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide: A Randomized Clinical Trial. Annals of Internal Medicine. 2025.
- 9.Kahan S, Fujioka K. Review article: Pharmacologic management of obesity: Updates on appetite suppressants and other anti-obesity medications. 2024.
- 10.University of Florida Health. Weight-Loss Medicines. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



